299 related articles for article (PubMed ID: 15587144)
21. Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients.
Moraloglu O; Kilic S; Karayalçin R; Yuksel B; Tasdemir N; Işik A; Ugur M
Adv Ther; 2008 Mar; 25(3):266-73. PubMed ID: 18345521
[TBL] [Abstract][Full Text] [Related]
22. GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study.
Aboulghar MA; Marie H; Amin YM; Aboulghar MM; Nasr A; Serour GI; Mansour RT
Reprod Biomed Online; 2015 Jan; 30(1):52-6. PubMed ID: 25456166
[TBL] [Abstract][Full Text] [Related]
23. Comparison between a GnRH agonist and a GnRH antagonist protocol for the same patient undergoing IVF.
Li Y; Li Y; Lai Q; Zhang H; Zhu G; Jin L; Yue J
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):618-20. PubMed ID: 18846352
[TBL] [Abstract][Full Text] [Related]
24. Precycle administration of GnRH antagonist and microdose HCG decreases clinical pregnancy rates without affecting embryo quality and blastulation.
Bukulmez O; Rehman KS; Langley M; Carr BR; Nackley AC; Doody KM; Doody KJ
Reprod Biomed Online; 2006 Oct; 13(4):465-75. PubMed ID: 17007662
[TBL] [Abstract][Full Text] [Related]
25. Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate.
Ochin H; Ma X; Wang L; Li X; Song J; Meng Y; Shen J; Cui YG; Liu J
J Ovarian Res; 2018 May; 11(1):37. PubMed ID: 29728130
[TBL] [Abstract][Full Text] [Related]
26. Gonadotrophin-releasing hormone antagonists for assisted conception.
Al-Inany H; Aboulghar M
Cochrane Database Syst Rev; 2001; (4):CD001750. PubMed ID: 11687120
[TBL] [Abstract][Full Text] [Related]
27. Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation.
Rongières-Bertrand C; Olivennes F; Righini C; Fanchin R; Taïeb J; Hamamah S; Bouchard P; Frydman R
Hum Reprod; 1999 Mar; 14(3):683-8. PubMed ID: 10221695
[TBL] [Abstract][Full Text] [Related]
28. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
[TBL] [Abstract][Full Text] [Related]
29. Reassessing the feasibility of the zygote score for predicting embryo viability in IVF/ICSI using the GnRH antagonist protocol compared to the long protocol.
Lin PY; Huang FJ; Kung FT; Lin YC; Chiang HJ; Lin YJ; Lan KC
PLoS One; 2017; 12(2):e0171465. PubMed ID: 28152037
[TBL] [Abstract][Full Text] [Related]
30. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
[TBL] [Abstract][Full Text] [Related]
31. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization.
Gibreel A; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2012 Nov; 11():CD008528. PubMed ID: 23152261
[TBL] [Abstract][Full Text] [Related]
32. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
33. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP; Macklon NS; Fauser BC
J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
[TBL] [Abstract][Full Text] [Related]
34. Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?
Craft I; Gorgy A; Hill J; Menon D; Podsiadly B
Hum Reprod; 1999 Dec; 14(12):2959-62. PubMed ID: 10601078
[TBL] [Abstract][Full Text] [Related]
35. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
[TBL] [Abstract][Full Text] [Related]
36. Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix.
Asimakopoulos B; Nikolettos N; Al-Hasani S
Reprod Biomed Online; 2002; 5 Suppl 1():52-6. PubMed ID: 12537782
[TBL] [Abstract][Full Text] [Related]
37. [A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization].
Ye H; Huang G; Pei L
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):222-5. PubMed ID: 11783366
[TBL] [Abstract][Full Text] [Related]
38. A novel strategy of using corifollitropin alfa in the ultrashort gonadotropin-releasing hormone agonist (GnRHa) protocol in unselected patients: A patient-friendly alternative.
Yu TN; Liu YL; Wang PH; Chen CH; Chen CH; Tzeng CR
Taiwan J Obstet Gynecol; 2019 Sep; 58(5):656-661. PubMed ID: 31542088
[TBL] [Abstract][Full Text] [Related]
39. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles.
Albano C; Smitz J; Tournaye H; Riethmüller-Winzen H; Van Steirteghem A; Devroey P
Hum Reprod; 1999 Jun; 14(6):1426-30. PubMed ID: 10357952
[TBL] [Abstract][Full Text] [Related]
40. Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI.
Mohsen IA; El Din RE
Gynecol Endocrinol; 2013 Feb; 29(2):105-8. PubMed ID: 23134528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]